Advent Pharma Ltd. (DSE:ADVENT)
13.10
-0.20 (-1.50%)
At close: Jan 21, 2026
Advent Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Net Income | 65.5 | 66.87 | 83.99 | 98.64 | 97.53 | 113.59 | Upgrade |
Depreciation & Amortization | 62.56 | 63.05 | 66.51 | 59.18 | 42.27 | 38.75 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | 29.61 | 0.02 | - | 0.39 | Upgrade |
Other Operating Activities | 28.52 | 28.53 | 29.68 | 38.47 | 38.36 | 24.42 | Upgrade |
Change in Accounts Receivable | -47.93 | -45.71 | -16.32 | -10.32 | -2.15 | 4.21 | Upgrade |
Change in Inventory | -4.22 | 1.07 | 12.51 | 0.78 | -5.12 | -7.53 | Upgrade |
Change in Accounts Payable | 0.59 | 0.44 | -10.96 | 10.83 | 1.08 | -1.31 | Upgrade |
Change in Other Net Operating Assets | 5.03 | 0.49 | -19.89 | 7.7 | 7.6 | 7.86 | Upgrade |
Operating Cash Flow | 110.04 | 114.74 | 175.13 | 205.3 | 179.57 | 180.38 | Upgrade |
Operating Cash Flow Growth | -26.86% | -34.48% | -14.69% | 14.33% | -0.45% | 6.05% | Upgrade |
Capital Expenditures | -93.54 | -94.18 | -162.06 | -202.73 | -191.13 | -184.06 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 2.7 | 0.68 | - | 0.23 | Upgrade |
Investment in Securities | - | - | - | - | 40 | - | Upgrade |
Investing Cash Flow | -93.54 | -94.18 | -159.36 | -202.06 | -151.13 | -183.83 | Upgrade |
Short-Term Debt Issued | - | - | 5.01 | 11.72 | 6.44 | 13.47 | Upgrade |
Total Debt Issued | 0.02 | - | 5.01 | 11.72 | 6.44 | 13.47 | Upgrade |
Short-Term Debt Repaid | - | -1.33 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -0.64 | -0.59 | -4.04 | -4.2 | -2.59 | Upgrade |
Total Debt Repaid | -1.82 | -1.97 | -0.59 | -4.04 | -4.2 | -2.59 | Upgrade |
Net Debt Issued (Repaid) | -1.79 | -1.97 | 4.42 | 7.68 | 2.25 | 10.88 | Upgrade |
Common Dividends Paid | -14.15 | -14.75 | -8.2 | -8.81 | -22.22 | -8.08 | Upgrade |
Other Financing Activities | -2.31 | -6.04 | -9.1 | -5.35 | -6.84 | -3.01 | Upgrade |
Financing Cash Flow | -18.25 | -22.76 | -12.88 | -6.48 | -26.82 | -0.21 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | - | - | Upgrade |
Net Cash Flow | -1.75 | -2.2 | 2.89 | -3.24 | 1.63 | -3.65 | Upgrade |
Free Cash Flow | 16.5 | 20.56 | 13.08 | 2.56 | -11.56 | -3.67 | Upgrade |
Free Cash Flow Growth | 1.23% | 57.25% | 409.89% | - | - | - | Upgrade |
Free Cash Flow Margin | 3.19% | 4.11% | 2.29% | 0.46% | -2.18% | -0.73% | Upgrade |
Free Cash Flow Per Share | 0.18 | 0.22 | 0.14 | 0.03 | -0.12 | -0.04 | Upgrade |
Cash Interest Paid | 6.04 | 6.04 | 9.1 | 5.35 | 6.83 | 3.01 | Upgrade |
Cash Income Tax Paid | 0.24 | 0.24 | 2.86 | 3.08 | 2.36 | 3.9 | Upgrade |
Levered Free Cash Flow | -18.97 | -20.56 | -36.41 | -44.03 | -68.27 | -56.36 | Upgrade |
Unlevered Free Cash Flow | -13.13 | -14.84 | -31.35 | -39.89 | -65.7 | -53.3 | Upgrade |
Change in Working Capital | -46.53 | -43.71 | -34.66 | 8.99 | 1.41 | 3.24 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.